E164-01-1 - Forschungsgruppe Massenspektrometrische Bio- und Polymeranalytik
-
Date (published):
20-May-2024
-
Event name:
MSB 2024
en
Event date:
19-May-2024 - 22-May-2024
-
Event place:
Brno, Czechia
-
Keywords:
Virus; virus-like particle; Chip electrophoresis
en
Abstract:
Chip electrophoresis of fluorescently labelled virus particles
Victor U. Weiss
Institute of Chemical Technologies and Analytics, TU Wien, Vienna, Austria
Capillary zone electrophoresis (CZE) on a commercially available chip electrophoretic platform has already been demonstrated in a series of papers [1, 2]. Focusing on fluorescently labelled particles of a human rhinovirus (common cold virus), it was possible to detect native, infectious virus particles and to separate virions from a co-purified contaminant, which was likewise modified via the applied fluorophore. Subsequent measurements followed the binding of virus particles to recombinant receptor molecules and receptor-decorated liposomes [3, 4]. Furthermore, the application of molecular beacons - small oligonucleotide probes showing a closed hairpin conformation in the absence of a complementary sequence and hence spatial proximity of a fluorophore and quencher - was possible, to target the release of the viral RNA genome [5].
On the basis of these experiments, we turned to the analysis of virus-like particles (VLPS) based on SARS-CoV2, the source of the recent COVID-19 pandemic. VLPs resemble native virions but no longer include the genomic material of the parent virus inside their core, hence, they are no longer infectious. We were able to demonstrate that also for this bionanoparticle analyte labelling via a fluorophore was possible. Resulting particles were still recognized by antibodies binding the VLP surface despite capsid modification via the applied dye. Nanoparticle tracking analysis enabled us to assess particle loss during the labelling process and subsequent removal steps of excess dye prior to CZE analysis. In overall, we found also CZE analysis of fluorescently labeled SARS-CoV2 VLPs possible via the chosen commercially available chip electrophoretic setup. Furthermore, we believe that CZE enables to target the question of VLP stability upon storage – an important parameter e.g. for VLP based vaccine development.
Literature:
[1] V. Kolivoska, V.U. Weiss, L. Kremser, B. Gas, D. Blaas, E. Kenndler, Electrophoresis on a microfluidic chip for analysis of fluorescence-labeled human rhinovirus, Electrophoresis 28 (2007) 4734-4740.
[2] V.U. Weiss, V. Kolivoska, L. Kremser, B. Gas, D. Blaas, E. Kenndler, Virus analysis by electrophoresis on a microfluidic chip, J Chromatogr B Analyt Technol Biomed Life Sci 860 (2007) 173-179.
[3] G. Bilek, V.U. Weiss, A. Pickl-Herk, D. Blaas, E. Kenndler, Chip electrophoretic characterization of liposomes with biological lipid composition: Coming closer to a model for viral infection, Electrophoresis 30 (2009) 4292-4299.
[4] V.U. Weiss, G. Bilek, A. Pickl-Herk, D. Blaas, E. Kenndler, Mimicking virus attachment to host cells employing liposomes: analysis by chip electrophoresis, Electrophoresis 30 (2009) 2123-2128.
[5] V.U. Weiss, C. Bliem, I. Gosler, S. Fedosyuk, M. Kratzmeier, D. Blaas, G. Allmaier, In vitro RNA release from a human rhinovirus monitored by means of a molecular beacon and chip electrophoresis, Anal Bioanal Chem 408 (2016) 4209-4217.
en
Research Areas:
Materials Characterization: 50% Biological and Bioactive Materials: 50%